Maven Semantic: Cancer Stem Cell Research Database

Search Over 47,000 People and Over 4,000 Cancer Stem Cell Research Organisations

DUBLIN--(BUSINESS WIRE)-- Maven Semantic ( announces updates to their Cancer Stem Cell research database.

The new database is now available to marketing, business development, competitor intelligence, KOL, medical affairs and related departments in the life sciences sector.

The database currently tags 47,000 individuals working in Cancer Stem Cell. .

Cancer stem cells (CSCs) are cancer cells (found within tumors or hematological cancers) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample. CSCs are therefore tumorigenic (tumor-forming), perhaps in contrast to other non-tumorigenic cancer cells. CSCs may generate tumors through the stem cell processes of self-renewal and differentiation into multiple cell types. Such cells are proposed to persist in tumors as a distinct population and cause relapse and metastasis by giving rise to new tumors. Therefore, development of specific therapies targeted at CSCs holds hope for improvement of survival and quality of life of cancer patients, especially for sufferers of metastatic disease.

Top 10 Countries for Cancer Stem Cell Research (ranked by number of senior Cancer Stem Cell researchers)

. United States Of America (19,200)

. Japan (4,447)

. Germany (3,100)

. United Kingdom (2,437)

. Italy (2,164)

. Canada (1,680)

. France (1,629)

. China (1,484)

. The Netherlands (968)

. Australia (843)

Leading organisations in Cancer Stem Cell research include:

. Harvard Medical School

. National Institutes of Health

. University of California

. Memorial Sloan-Kettering Cancer Center

. Fred Hutchinson Cancer Research Center

. National Cancer Institute

. Dana-Farber Cancer Institute

. Duke University Medical Center

. Washington University School of Medicine

. Baylor College of Medicine

. Indiana University School of Medicine

. Stanford University School of Medicine

. The University of Texas M. D. Anderson Cancer Center

. Massachusetts General Hospital

. Kyoto University

. Terry Fox Laboratory

. University of Cambridge

. University of Pennsylvania

. St. Jude Children's Research Hospital

. Karolinska Institutet

. Leiden University Medical Center

. Osaka University

. Medical College of Wisconsin

. Keio University

. University of Ulm

The database also includes pharmaceutical companies, biotech companies, CROs, hospitals, government labs and other organisations active in the Cancer Stem Cell research field.

Sample companies in database include:

. Genentech, Inc

. Amgen Inc

. ChemoCentryx, Inc

. Cross Cancer Institute, AB

. Immunex Corporation

. Kirin Brewery Co., Ltd

. Celgene Corporation

. AntiCancer, Inc

. Genzyme Corporation

. Geron Corporation

. Daiichi Pharmaceutical Co., Ltd

. Millennium Pharmaceuticals, Inc

. Novartis Pharma AG

. Seattle Genetics, Inc

. Baxter Healthcare Corporation

. Chugai Pharmaceutical Co., Ltd

. Eli Lilly and Company

. Fujisawa Healthcare, Inc

. Immunomedics, Inc

. MethylGene Inc

. Sandoz Pharma Ltd

. Shionogi & Co., Ltd

. US Oncology Research, Inc

. AnorMED Inc

What is Maven:

- Largest database of international medical professionals, with over 6,000,000 people and over 500,000 medical organisations;

- All records are downloadable to excel or in-house database, with email, postal address and phone contacts;

- Profile and segment the entire database using over 47,000 diseases and therapeutic areas

What is Maven used for:

- Building prospect lists for postal, telesales and email campaigns

- Locating key decision makers in companies, hospitals, government labs, university labs, and other healthcare facilities

- Identifying candidates for recruitment to very specific life science positions

About the Maven Semantic Medical Database: The current database holds over 6 million medical professionals, and 500,000 medical organisations.

The Maven Semantic medical database covers pharmaceutical, biotech and medical device companies, clinical research labs, hospitals, medical universities and government research organisations.

Maven is a SaaS subscription-based service. Clients can choose from quarterly or yearly subscriptions, or as pay-as-you-go option to retrieve specific large datasets for in-house use.

Results can be viewed online, or exported to Excel or a CRM system.

The data is now available to international healthcare marketing teams.

About our Technology: Semantic data mining tools have been used to create a database of detailed profiles of life science companies and executives.

The system uses the open web as an underlying database and extracts specific information on people, job titles, biographies, research profiles, contact details (dept., phone, fax, and email), organisation profiles, websites, product/services and much more.

Maven is based on healthcare crawlers/bots, search technology, semantic parsers, clustering, natural language processing (NLP) and artificial intelligence (AI) technology.

"The system uses the context in which a given person appears, using artificial intelligence techniques to find out information not otherwise visible - for example, how important is this person in a specific medical research specialization," says Alejandro Mesas, Semantic Systems Architect. "The big advantage of a focused semantic healthcare database over a generic search engine is that it has built-in taxonomies and a thesaurus to expand and refine the user queries. We then use scoring and ranking to fine tune the relevance of the results for a given therapeutic area. For example, stem cell researchers are given a "page rank", based on where they work, their job title, how many times they have published, where they have published, etc. The relevance can be fine tuned by the user".

For more information visit


Maven Semantic
Bryan McManmon
[email protected]
Ph: + 353 1 4100699

KEYWORDS:   Australia  United States  Europe  Asia Pacific  North America  Australia/Oceania

INDUSTRY KEYWORDS:   Stem Cells  Health  Biotechnology  Hospitals  Oncology  Pharmaceutical